Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

SQI Diagnostics Inc SQIDF


Primary Symbol: V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

Comment by FactFinder1994on Mar 03, 2023 3:01pm
118 Views
Post# 35318264

RE:UHN Organ Lab - worlds first

RE:UHN Organ Lab - worlds firstThis is truely exceptional stuff, on a global perspective!  
To think that SQI's piece is so important to this effort is also gratifying.  
The total addressable market here is in the $100's of millions just for SQI.  
Think about what this is worth the hospitals....If they double or tripple the number of Lung transplants they do....At over a Million dollars per transplant with half of it as profit.  
Even if you think tiny....
Consider the profit as a result of the organ scoring SQI provides.... 
Every additional thousand transplants generated as a result of SQI's scoring means...
1,000 incremental Lung Transplants X $500,000 profit/ = $500,000,000.  That's half a billion collectively in profit to the hospitals.  
There is plently of incentive for this tecnology, its just not well known.  Anyone that has the knowledge of the opportunity and the ability to do math can figure it out.
Now do the math with a higher more realistic number of organs....$BILLIONS - YES this one piece of SQI creates Billions in Profit for Collective Hospitals.  And Hundreds of Millions for SQI.   

<< Previous
Bullboard Posts
Next >>